Elanco Animal Health (ELAN) Goodwill & Intangibles (2017 - 2026)
Elanco Animal Health (ELAN) reported Goodwill & Intangibles of $7.9 billion for Q1 2026, down 2.38% on a YoY basis from $8.1 billion in Q1 2025, and down 2.92% sequentially from $8.2 billion in Q4 2025.
Elanco Animal Health (ELAN) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Goodwill & Intangibles data on file, last reported at $7.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles fell 2.38% year-over-year to $7.9 billion; the trailing twelve-month figure through Mar 2026 stood at $7.9 billion (down 2.38% YoY), and the FY2025 full-year result was $8.2 billion, up 1.14% from the prior year.
- Goodwill & Intangibles slipped to $7.9 billion in Q1 2026, from $8.2 billion in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $11.5 billion in Q1 2022 to a low of $7.9 billion in Q1 2026.
- A 5-year average of $9.4 billion and a median of $8.7 billion in 2024 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles slipped 20.88% in 2024 and climbed 1.14% in 2025, its largest moves.
- Tracing ELAN's Goodwill & Intangibles over 5 years: stood at $10.8 billion in 2022, then dropped by 11.51% to $9.6 billion in 2023, then fell by 15.57% to $8.1 billion in 2024, then increased by 1.14% to $8.2 billion in 2025, then declined by 2.92% to $7.9 billion in 2026.
- Business Quant data shows ELAN's Goodwill & Intangibles at $7.9 billion in Q1 2026, $8.2 billion in Q4 2025, and $8.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.95 Bn |
| Dec 31, 2025 | 8.19 Bn |
| Sep 30, 2025 | 8.36 Bn |
| Jun 30, 2025 | 8.46 Bn |
| Mar 31, 2025 | 8.14 Bn |
| Dec 31, 2024 | 8.10 Bn |
| Sep 30, 2024 | 8.64 Bn |
| Jun 30, 2024 | 8.48 Bn |
| Mar 31, 2024 | 8.67 Bn |
| Dec 31, 2023 | 9.59 Bn |
| Sep 30, 2023 | 9.38 Bn |
| Jun 30, 2023 | 10.72 Bn |
| Mar 31, 2023 | 10.85 Bn |
| Dec 31, 2022 | 10.84 Bn |
| Sep 30, 2022 | 10.48 Bn |
| Jun 30, 2022 | 10.96 Bn |
| Mar 31, 2022 | 11.51 Bn |
| Dec 31, 2021 | 11.76 Bn |
| Sep 30, 2021 | 12.01 Bn |
| Jun 30, 2021 | 11.99 Bn |